Abstract
Endogenous cholecystokinin tetrapeptide (CCK-4, Trp-Met-Asp-Phe-NH2) is a fragment derived from a larger peptide hormone, cholecystokinin (or gastrin). As a panicogenic agent, CCK-4 is commonly used in clinic settings to induce panic attacks for the study of new anxiolytic drugs. However, few studies on CCK-4 metabolism have been published to date. In the present study, we investigate the metabolism of CCK-4 in liver microsomes of human (HLM), Rhesus Monkey (RMLM), Sprague-Dawley rat (RLM) and CD1 mouse (MLM) using ultra-high performance liquid chromatography coupled to a high resolution mass spetrometer. Ten metabolites, inlcuding tryptophan (M1), tryptophan amide (M2), hydroxy metabolites (M3-M5), truncated peptides (M6-M9), and CCK-4 acid (M10), were identified and 8 of them were reported for the first time. The metabolic pattern of CCK-4 in HLM was distinctly different from these in RMLM, RLM, and MLM. M2 and M9 were the major metabolites in HLM and accounted for 19.8% and 13.4% of initial CCK-4, respectively. In contrast, M2 was the major metabolite in RMLM and accounted for 41.4%, whereas M6 was the major metabolite in RLM and account for 39.1%. Three major metabolites M2, M7 and M8 in MLM accounted for 22.6%, 17.9% and 1...Continue Reading
References
Dec 9, 1976·Nature·G J Dockray
Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P RobberechtJ J Vanderhaeghen
Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E StrausR S Yalow
Oct 16, 1975·Nature·J J VanderhaeghenW Gepts
Jul 1, 1991·Archives of General Psychiatry·J BradwejnC Shriqui
Aug 1, 1989·The American Journal of Physiology·G J GoresJ J Lemasters
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C RoseJ C Schwartz
Feb 7, 1983·FEBS Letters·M Deschodt-Lanckman, A D Strosberg
Apr 1, 1981·Regulatory Peptides·M Deschodt-LanckmanJ Christophe
Aug 1, 1982·Regulatory Peptides·D KoulischerM Deschodt-Lanckman
Jan 1, 1983·Peptides·M Deschodt-LanckmanA D Strosberg
Nov 1, 1984·Biomedical Mass Spectrometry·P Roepstorff, J Fohlman
Jan 1, 1982·Regulatory Peptides·J F RehfeldS L Jensen
Apr 1, 1982·Journal of Neurochemistry·P C EmsonM N Rossor
Aug 1, 1995·The American Journal of Psychiatry·C BenkelfatA Evans
Sep 1, 1993·Biomedical Chromatography : BMC·G A QureshiM Thörnwall
Jan 1, 1997·Peptides·S MeraniJ Gutkowska
Apr 2, 2002·Biochemical and Biophysical Research Communications·Sheng-Fang SuHye J Lee
Nov 1, 2002·Life Sciences·Sheng-Fang SuHye J Lee
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Chie EmotoKazuhide Iwasaki
Mar 1, 2005·Basic & Clinical Pharmacology & Toxicology·Olavi PelkonenHannu Raunio
May 24, 2005·Biochemical Pharmacology·Inger BrandtAnne-Marie Lambeir
Apr 20, 2006·Amino Acids·M Werle, A Bernkop-Schnürch
Feb 24, 2007·Psychopharmacology·Daniela EserRainer Rupprecht
Jun 15, 2007·Critical Reviews in Biochemistry and Molecular Biology·Mirko Koppen, Thomas Langer
Dec 21, 2007·Human Brain Mapping·Daniela EserChristoph Mulert
Jan 6, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xiao-Chi MaLing Yang
Jun 24, 2011·Mass Spectrometry Reviews·Theodora KatsilaConstantin Tamvakopoulos
Mar 15, 2012·Peptides·Diana KoszyckiJacques Bradwejn